Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 5/8/2020
SIETES contiene 93082 citas

 
 
 1 a 20 de 1036 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Hart LA, Phelan EA, Yi JY, Marcum ZA, Gray SL. Use of fall eisk-increasing drugs around a fall-related injury in older adults: a systematic review. J Am Geriatr Soc 2020;68:junio. [Ref.ID 103662]
2. Cita con resumen
Niznik JD, Zhao X, He M, Aspinall SL, Hanlon JT, Hanson LC, Nace D, Thorpe JM, Thorpe CT. Risk for health events after deprescribing acetylcholinesterase inhibitors in nursing home residents with severe dementia. J Am Geriatr Soc 2020;68:699-707. [Ref.ID 103640]
3.Enlace a cita original Cita con resumen
Wang Y-H, Wintzell V, Ludvigsson JF, Svanström H, Pasterenak B. Association between proton pump inhibitor use and risk of fracture in children. JAMA Pediatrics 2020:1. [Ref.ID 103566]
4.Enlace a cita original Cita con resumen
Lutsey PL, Norby FL, Ensrud KE, MacLehose RF, Diem SJ, Chen LY, Alonso A. Association of anticoagulant therapy with risk of fracture among patients with atrial fibrillation. JAMA Intern Med 2019:25 de noviembre. [Ref.ID 103220]
5. Cita con resumen
Thayakaran R, Adderley NJ, Sainsbury C, Torlinska B, Sumilo D, Thomas GN, Toulis KA, Nirantharakumar K. Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study. BMJ 2019;366:3 de septiembre. [Ref.ID 103172]
6.Tiene citas relacionadas Cita con resumen
Montero-Odasso M, Sarquis-Adamson Y, Song HY, Bray NW, Pieruccini-Faria F, Speechley M. Polypharmacy, gait performance, and falls in community-dwelling older adults. Results from the Gait and Brain Study. J Am Geriatr Soc 2019;67:junio. [Ref.ID 103158]
7. Cita con resumen
Randolph AC, Lin Y-L, Volpi E, Kuo Y-F. Tricyclic antidepressant and/or ?-aminobutyric acid–analog use is associated with fall risk in diabetic peripheral neuropathy. J Am Geriatr Soc 2019;67:junio. [Ref.ID 103149]
8.Enlace a cita original Cita con resumen
Schiek S, Hildebrandt K, Zube O, Bertsche T. Fall-risk-increasing adverse reactions - is there value in easily accessible drug information? A case-control study. Eur J Clin Pharmacol 2019;75:junio. [Ref.ID 103137]
9.Enlace a cita original Cita con resumen
Brännström J, Lövheim H, Gustafson Y, Nordström P. Association between antidepressant drug use and hip fracture in older people before and after treatment initiation. JAMA Psychiatry 2019:2 de enero. [Ref.ID 103000]
10.Enlace a cita original Cita con resumen
Ueda P, Svanström H, Melbye M, Eliasson B, Svensson A-M, Franzén S, Gudbjörnsdottir S, Hveem K, Jonasson C, Pasternak B. Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study. BMJ 2018;363:14 de noviembre. [Ref.ID 102869]
11.Enlace a cita original Cita con resumen
Asensio C, Escoda N, Sabaté M, Carbonell P, López P, Laporte JR. Prevalence of use of antipsychotic drugs in the elderly in Catalonia. Eur J Clin Pharmacol 2018;74:septiembre. [Ref.ID 102828]
12.Enlace a cita original Cita con resumen
Harding BN, Weiss NS, Walker RL, Larson EB, Dublin S. Proton pump inhibitor use and the risk of fractures among an older adult cohort. Pharmacoepidemiol Drug Saf 2018;27:junio. [Ref.ID 102801]
13.Enlace a cita originalTiene citas relacionadas Cita con resumen
Guirguis-Blake JM, Michael YL, Perdue LA, Coppola EL, Beil TL. Interventions to prevent falls in older adults. Updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 2018;319:24 de abril. [Ref.ID 102686]
14.Enlace a cita originalTiene citas relacionadas Cita con resumen
17.Enlace a cita originalTiene citas relacionadas Cita con resumen
Bischoff-Ferrari HA, Bhasin S, Manson JAE. Preventing fractures and falls. A limited role for calcium and vitamin D supplements?. JAMA 2018;319:17 de abril. [Ref.ID 102673]
18.Enlace a cita originalTiene citas relacionadas Cita con resumen
Tsourdi E, Rachner TD, Hofbauer LC. Romosozumab versus alendronate and fracture risk in women with osteoporosis. N Engl J Med 2018;378:11 de enero. [Ref.ID 102629]
19.Enlace a cita originalTiene citas relacionadas Cita con resumen
Lewis JR, Schousboe JT, Prince RL. Romosozumab versus alendronate and fracture risk in women with osteoporosis. N Engl J Med 2018;378:11 de enero. [Ref.ID 102628]
20.Enlace a cita originalTiene citas relacionadas Cita con resumen
Song GG, Lee YH. Romosozumab versus alendronate and fracture risk in women with osteoporosis. N Engl J Med 2018;378:11 de enero. [Ref.ID 102627]
Seleccionar todas
 
 1 a 20 de 1036 siguiente >>